Sodium 4-Phenylbutyrate>98.0%(HPLC)(T)1g

Butanoic acid, 2,4-bis[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-, 98%, 10g

4-((4-Bromo-2-methylphenyl)sulfonyl)morpholine, 97%, 250mg

5-Methanesulfonyl-1H-indole-3-carboxylic acid, 95%, 250mg

(S)-3-((tert-Butoxycarbonyl)amino)-3-(p-tolyl)propanoic acid, 95.0%, 100mg

Tripropylene Glycol Monomethyl Ether (mixture of isomer)>93.0%(GC)500g

tert-Butyl 7-bromo-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylate, 95+%, 250mg

1-[4-(1H-benzimidazol-1-yl)phenyl]ethanone, 250mg

5-Bromo-2,3-dihydroxybenzoic acid, 95+%, 250mg

2-Methoxythiazole>98.0%(GC)5g

Naringina, minimo 98%, 50 g, confezione in plastica.

1-(2,2,2-trifluoroethyl)piperazine, 95.0%, 25g

3,6-Dibromo-9-(4-dodecyloxyphenyl)-9H-carbazole, 98%, 1g